TreeWAS – Variant ID: rs2290203

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.000	0.642	0.358
C79 Secondary malignant neoplasm of other sites	0.000	0.644	0.356
C79.9 Secondary malignant neoplasm, unspecified site	0.000	0.668	0.332
C79.7 Secondary malignant neoplasm of adrenal gland	0.000	0.671	0.329
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.000	0.679	0.321
C79.8 Secondary malignant neoplasm of other specified sites	0.000	0.686	0.314
C79.6 Secondary malignant neoplasm of ovary	0.000	0.700	0.300
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.000	0.709	0.291
C79.2 Secondary malignant neoplasm of skin	0.000	0.742	0.258
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.000	0.809	0.191
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.000	0.819	0.180
E11 Non-insulin-dependent diabetes mellitus	0.173	0.827	0.000
E11.4 With neurological complications	0.166	0.834	0.000
E10-E14 Diabetes mellitus	0.165	0.835	0.000
E11.3 With ophthalmic complications	0.165	0.835	0.000
E14 Unspecified diabetes mellitus	0.161	0.839	0.000
E11.2 With renal complications	0.155	0.845	0.000
E10 Insulin-dependent diabetes mellitus	0.151	0.849	0.000
E11.9 Without complications	0.150	0.850	0.000
E14.9 Without complications	0.148	0.852	0.000
E10.3 With ophthalmic complications	0.140	0.860	0.000
E11.5 With peripheral circulatory complications	0.139	0.861	0.000
E10.5 With peripheral circulatory complications	0.135	0.865	0.000
E14.3 With ophthalmic complications	0.132	0.868	0.000
E10.0 With coma	0.129	0.871	0.000
E14.6 With other specified complications	0.128	0.872	0.000
E14.5 With peripheral circulatory complications	0.126	0.874	0.000
E11.7 With multiple complications	0.124	0.876	0.000
E14.4 With neurological complications	0.124	0.876	0.000
E11.8 With unspecified complications	0.121	0.879	0.000
E13 Other specified diabetes mellitus	0.121	0.879	0.000
E11.0 With coma	0.120	0.880	0.000
E10.6 With other specified complications	0.119	0.880	0.000
E12 Malnutrition-related diabetes mellitus	0.119	0.881	0.000
E14.2 Withrenal complications	0.117	0.883	0.000
E14.7 With multiple complications	0.115	0.885	0.000
E14.1 With ketoacidosis	0.115	0.885	0.000
E14.0 With coma	0.115	0.885	0.000
E11.6 With other specified complications	0.112	0.888	0.000
E10.7 With multiple complications	0.109	0.891	0.000
E10.2 With renal complications	0.108	0.892	0.000
E14.8 With unspecified complications	0.104	0.896	0.000
E10.1 With ketoacidosis	0.099	0.901	0.000
E10.9 Without complications	0.090	0.910	0.000
E13.9 Without complications	0.089	0.911	0.000
E10.4 With neurological complications	0.088	0.912	0.000
E13.8 With unspecified complications	0.087	0.913	0.000
E13.7 With multiple complications	0.087	0.913	0.000
E13.6 With other specified complications	0.087	0.913	0.000
E13.5 With peripheral circulatory complications	0.087	0.913	0.000
E13.4 With neurological complications	0.087	0.913	0.000
E13.3 With ophthalmic complications	0.087	0.913	0.000
E13.2 With renal complications	0.087	0.913	0.000
E13.1 With ketoacidosis	0.087	0.913	0.000
E13.0 With coma	0.087	0.913	0.000
E12.9 Without complications	0.085	0.915	0.000
E12.8 With unspecified complications	0.085	0.915	0.000
E12.7 With multiple complications	0.085	0.915	0.000
E12.6 With other specified complications	0.085	0.915	0.000
E12.5 With peripheral circulatory complications	0.085	0.915	0.000
E12.4 With neurological complications	0.085	0.915	0.000
E12.3 With ophthalmic complications	0.085	0.915	0.000
E12.2 With renal complications	0.085	0.915	0.000
E12.1 With ketoacidosis	0.085	0.915	0.000
E12.0 With coma	0.085	0.915	0.000
E10.8 With unspecified complications	0.064	0.935	0.001
E11.1 With ketoacidosis	0.062	0.937	0.001
T46 Poisoning by agents primarily affecting the cardiovascular system	0.044	0.956	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.044	0.956	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.043	0.957	0.000
T46.1 Calcium-channel blockers	0.041	0.959	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.040	0.960	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.040	0.960	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.037	0.963	0.000
T42.4 Benzodiazepines	0.037	0.963	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.036	0.964	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.036	0.964	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.036	0.964	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.035	0.965	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.035	0.965	0.000
T42.1 Iminostilbenes	0.035	0.965	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.035	0.965	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.035	0.965	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.034	0.966	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.034	0.966	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.033	0.966	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.033	0.966	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.033	0.967	0.000
T36 Poisoning by systemic antibiotics	0.033	0.967	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.033	0.967	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.032	0.968	0.000
T40.6 Other and unspecified narcotics	0.032	0.968	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.032	0.968	0.000
T46.7 Peripheral vasodilators	0.032	0.968	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.032	0.968	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.032	0.968	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.032	0.968	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.032	0.968	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.032	0.968	0.000
T42.0 Hydantoin derivatives	0.031	0.969	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.031	0.969	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.031	0.969	0.000
T42.3 Barbiturates	0.031	0.969	0.000
T42.2 Succinimides and oxazolidinediones	0.031	0.969	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.029	0.971	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.029	0.971	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.029	0.971	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.029	0.971	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.029	0.971	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.029	0.971	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.029	0.971	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.029	0.971	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.029	0.971	0.000
T44.0 Anticholinesterase agents	0.029	0.971	0.000
T40.2 Other opioids	0.029	0.971	0.000
T39.4 Antirheumatics, not elsewhere classified	0.028	0.971	0.000
T39.2 Pyrazolone derivatives	0.028	0.971	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.028	0.972	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.028	0.972	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.027	0.973	0.000
T40.8 Lysergide [LSD]	0.027	0.973	0.000
T40.7 Cannabis (derivatives)	0.027	0.973	0.000
T40.5 Cocaine	0.027	0.973	0.000
T40.3 Methadone	0.027	0.973	0.000
T40.1 Heroin	0.027	0.973	0.000
T40.0 Opium	0.027	0.973	0.000
T40.4 Other synthetic narcotics	0.027	0.973	0.000
T48.5 Anti-common-cold drugs	0.026	0.973	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.026	0.974	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.000	0.975	0.025
T36.0 Penicillins	0.025	0.975	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.024	0.975	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.024	0.975	0.000
T48.4 Expectorants	0.024	0.975	0.000
T48.3 Antitussives	0.024	0.975	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.024	0.975	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.024	0.975	0.000
T48.0 Oxytocic drugs	0.024	0.975	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.024	0.976	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.024	0.976	0.000
T47.7 Emetics	0.024	0.976	0.000
T47.6 Antidiarrhoeal drugs	0.024	0.976	0.000
T47.5 Digestants	0.024	0.976	0.000
T47.4 Other laxatives	0.024	0.976	0.000
T47.3 Saline and osmotic laxatives	0.024	0.976	0.000
T47.2 Stimulant laxatives	0.024	0.976	0.000
T47.0 Histamine H(2)-receptor antagonists	0.024	0.976	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.024	0.976	0.000
T36.9 Systemic antibiotic, unspecified	0.024	0.976	0.000
T36.8 Other systemic antibiotics	0.024	0.976	0.000
T36.7 Antifungal antibiotics, systemically used	0.024	0.976	0.000
T36.6 Rifamycins	0.024	0.976	0.000
T36.5 Aminoglycosides	0.024	0.976	0.000
T36.4 Tetracyclines	0.024	0.976	0.000
T36.3 Macrolides	0.024	0.976	0.000
T36.2 Chloramphenicol group	0.024	0.976	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.024	0.976	0.000
I50.9 Heart failure, unspecified	0.000	0.976	0.024
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.023	0.977	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.023	0.977	0.000
T37.5 Antiviral drugs	0.023	0.977	0.000
T37.4 Anthelminthics	0.023	0.977	0.000
T37.3 Other antiprotozoal drugs	0.023	0.977	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.023	0.977	0.000
T37.1 Antimycobacterial drugs	0.023	0.977	0.000
T37.0 Sulphonamides	0.023	0.977	0.000
T41.5 Therapeutic gases	0.023	0.977	0.000
T41.4 Anaesthetic, unspecified	0.023	0.977	0.000
T41.3 Local anaesthetics	0.023	0.977	0.000
T41.2 Other and unspecified general anaesthetics	0.023	0.977	0.000
T41.1 Intravenous anaesthetics	0.023	0.977	0.000
T41.0 Inhaled anaesthetics	0.023	0.977	0.000
T49.9 Topical agent, unspecified	0.023	0.977	0.000
T49.8 Other topical agents	0.023	0.977	0.000
T49.7 Dental drugs, topically applied	0.023	0.977	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.023	0.977	0.000
T49.5 Ophthalmological drugs and preparations	0.023	0.977	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.023	0.977	0.000
T49.3 Emollients, demulcents and protectants	0.023	0.977	0.000
T49.2 Local astringents and local detergents	0.023	0.977	0.000
T49.1 Antipruritics	0.023	0.977	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.023	0.977	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.022	0.978	0.000
T50.8 Diagnostic agents	0.022	0.978	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.022	0.978	0.000
T38.1 Thyroid hormones and substitutes	0.021	0.979	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.021	0.979	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.021	0.979	0.000
T50.7 Analeptics and opioid receptor antagonists	0.021	0.979	0.000
T50.5 Appetite depressants	0.021	0.979	0.000
T50.4 Drugs affecting uric acid metabolism	0.021	0.979	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.021	0.979	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.021	0.979	0.000
T50.1 Loop [high-ceiling] diuretics	0.021	0.979	0.000
T50.0 Mineralocorticoids and their antagonists	0.021	0.979	0.000
T38.9 Other and unspecified hormone antagonists	0.021	0.979	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.021	0.979	0.000
T38.7 Androgens and anabolic congeners	0.021	0.979	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.021	0.979	0.000
T38.5 Other oestrogens and progestogens	0.021	0.979	0.000
T38.4 Oral contraceptives	0.021	0.979	0.000
T38.2 Antithyroid drugs	0.021	0.979	0.000
T38.0 Glucocorticoids and synthetic analogues	0.021	0.979	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.021	0.979	0.000
T45.0 Antiallergic and antiemetic drugs	0.021	0.979	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.020	0.980	0.000
T45.8 Other primarily systemic and haematological agents	0.020	0.980	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.020	0.980	0.000
T45.6 Fibrinolysis-affecting drugs	0.020	0.980	0.000
T45.4 Iron and its compounds	0.020	0.980	0.000
T45.3 Enzymes, not elsewhere classified	0.020	0.980	0.000
T43.9 Psychotropic drug, unspecified	0.020	0.980	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.020	0.980	0.000
T45.2 Vitamins, not elsewhere classified	0.019	0.981	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.019	0.981	0.000
T39.1 4-Aminophenol derivatives	0.018	0.982	0.000
C80 Malignant neoplasm without specification of site	0.000	0.982	0.018
T39.0 Salicylates	0.017	0.982	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.017	0.983	0.000
T45.5 Anticoagulants	0.017	0.983	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.000	0.983	0.017
T43.6 Psychostimulants with abuse potential	0.016	0.983	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.014	0.986	0.000
C80.9 Malignant neoplasm, unspecified	0.000	0.987	0.013
C76.0 Head, face and neck	0.000	0.987	0.013
C80.0 Malignant neoplasm, primary site unknown, so stated	0.000	0.987	0.013
C76.1 Thorax	0.000	0.987	0.012
C76.8 Overlapping lesion of other and ill-defined sites	0.000	0.988	0.012
C76.7 Other ill-defined sites	0.000	0.988	0.012
C76.5 Lower limb	0.000	0.988	0.012
C76.4 Upper limb	0.000	0.988	0.012
C76.3 Pelvis	0.000	0.988	0.012
K51.2 Ulcerative (chronic) proctitis	0.011	0.989	0.000
C76.2 Abdomen	0.000	0.990	0.010
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.000	0.991	0.009
Z90.1 Acquired absence of breast(s)	0.000	0.991	0.009
C78.2 Secondary malignant neoplasm of pleura	0.000	0.992	0.008
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.000	0.993	0.007
Z85.3 Personal history of malignant neoplasm of breast	0.000	0.993	0.007
C78.0 Secondary malignant neoplasm of lung	0.000	0.993	0.007
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.000	0.993	0.007
C78.1 Secondary malignant neoplasm of mediastinum	0.000	0.993	0.007
N08 Glomerular disorders in diseases classified elsewhere	0.007	0.993	0.000
N08.5 Glomerular disorders in systemic connective tissue disorders	0.007	0.993	0.000
Y43.3 Other antineoplastic drugs	0.000	0.994	0.006
N04 Nephrotic syndrome	0.006	0.994	0.000
N00-N08 Glomerular diseases	0.006	0.994	0.000
N08.3 Glomerular disorders in diabetes mellitus	0.006	0.994	0.000
N04.9 Unspecified	0.006	0.994	0.000
Z71.9 Counselling, unspecified	0.006	0.994	0.000
N05 Unspecified nephritic syndrome	0.006	0.994	0.000
N02 Recurrent and persistent haematuria	0.006	0.994	0.000
N02.2 Diffuse membranous glomerulonephritis	0.006	0.994	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.000	0.994	0.006
T43.2 Other and unspecified antidepressants	0.005	0.994	0.000
H36.0 Diabetic retinopathy	0.005	0.995	0.000
N04.2 Diffuse membranous glomerulonephritis	0.005	0.995	0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.000	0.995	0.005
N05.7 Diffuse crescentic glomerulonephritis	0.005	0.995	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.000	0.995	0.005
N08.8 Glomerular disorders in other diseases classified elsewhere	0.005	0.995	0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.005	0.995	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.005	0.995	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.005	0.995	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.005	0.995	0.000
N04.1 Focal and segmental glomerular lesions	0.005	0.995	0.000
N05.9 Unspecified	0.005	0.995	0.000
N05.2 Diffuse membranous glomerulonephritis	0.005	0.995	0.000
N02.9 Unspecified	0.005	0.995	0.000
N04.8 Other	0.005	0.995	0.000
N04.7 Diffuse crescentic glomerulonephritis	0.005	0.995	0.000
N04.6 Dense deposit disease	0.005	0.995	0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis	0.005	0.995	0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis	0.005	0.995	0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis	0.005	0.995	0.000
N04.0 Minor glomerular abnormality	0.005	0.995	0.000
N07 Hereditary nephropathy, not elsewhere classified	0.005	0.995	0.000
N06 Isolated proteinuria with specified morphological lesion	0.005	0.995	0.000
N01 Rapidly progressive nephritic syndrome	0.005	0.995	0.000
N00 Acute nephritic syndrome	0.005	0.995	0.000
N05.6 Dense deposit disease	0.004	0.996	0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.004	0.996	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.004	0.996	0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.004	0.996	0.000
N05.0 Minor glomerular abnormality	0.004	0.996	0.000
N05.1 Focal and segmental glomerular lesions	0.004	0.996	0.000
N02.7 Diffuse crescentic glomerulonephritis	0.004	0.996	0.000
N02.6 Dense deposit disease	0.004	0.996	0.000
N02.5 Diffuse mesangiocapillary glomerulonephritis	0.004	0.996	0.000
N02.4 Diffuse endocapillary proliferative glomerulonephritis	0.004	0.996	0.000
N02.3 Diffuse mesangial proliferative glomerulonephritis	0.004	0.996	0.000
N02.1 Focal and segmental glomerular lesions	0.004	0.996	0.000
N02.0 Minor glomerular abnormality	0.004	0.996	0.000
N05.8 Other	0.004	0.996	0.000
K90.9 Intestinal malabsorption, unspecified	0.004	0.996	0.000
S64.4 Injury of digital nerve of other finger	0.000	0.996	0.004
D72.8 Other specified disorders of white blood cells	0.004	0.996	0.000
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.000	0.996	0.004
M25.96 Joint disorder, unspecified (Lower leg)	0.004	0.996	0.000
M95.0 Acquired deformity of nose	0.000	0.996	0.004
N02.8 Other	0.004	0.996	0.000
N00.9 Unspecified	0.003	0.996	0.000
N00.8 Other	0.003	0.996	0.000
N00.7 Diffuse crescentic glomerulonephritis	0.003	0.996	0.000
N00.6 Dense deposit disease	0.003	0.996	0.000
N00.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.996	0.000
N00.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.996	0.000
N00.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.996	0.000
N00.2 Diffuse membranous glomerulonephritis	0.003	0.996	0.000
N00.1 Focal and segmental glomerular lesions	0.003	0.996	0.000
N00.0 Minor glomerular abnormality	0.003	0.996	0.000
N01.9 Unspecified	0.003	0.996	0.000
N01.8 Other	0.003	0.996	0.000
N01.7 Diffuse crescentic glomerulonephritis	0.003	0.996	0.000
N01.6 Dense deposit disease	0.003	0.996	0.000
N01.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.996	0.000
N01.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.996	0.000
N01.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.996	0.000
N01.2 Diffuse membranous glomerulonephritis	0.003	0.996	0.000
N01.1 Focal and segmental glomerular lesions	0.003	0.996	0.000
N01.0 Minor glomerular abnormality	0.003	0.996	0.000
N06.9 Unspecified	0.003	0.996	0.000
N06.8 Other	0.003	0.996	0.000
N06.7 Diffuse crescentic glomerulonephritis	0.003	0.996	0.000
N06.6 Dense deposit disease	0.003	0.996	0.000
N06.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.996	0.000
N06.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.996	0.000
N06.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.996	0.000
N06.2 Diffuse membranous glomerulonephritis	0.003	0.996	0.000
N06.1 Focal and segmental glomerular lesions	0.003	0.996	0.000
N06.0 Minor glomerular abnormality	0.003	0.996	0.000
N07.9 Unspecified	0.003	0.996	0.000
N07.8 Other	0.003	0.996	0.000
N07.7 Diffuse crescentic glomerulonephritis	0.003	0.996	0.000
N07.6 Dense deposit disease	0.003	0.996	0.000
N07.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.996	0.000
N07.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.996	0.000
N07.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.996	0.000
N07.2 Diffuse membranous glomerulonephritis	0.003	0.996	0.000
N07.1 Focal and segmental glomerular lesions	0.003	0.996	0.000
N07.0 Minor glomerular abnormality	0.003	0.996	0.000
H46 Optic neuritis	0.004	0.996	0.000
C78.7 Secondary malignant neoplasm of liver	0.000	0.997	0.003
Z71.3 Dietary counselling and surveillance	0.003	0.997	0.000
J00 Acute nasopharyngitis [common cold]	0.003	0.997	0.000
N03 Chronic nephritic syndrome	0.003	0.997	0.000
G80.0 Spastic cerebral palsy	0.003	0.997	0.000
G80.1 Spastic diplegia	0.003	0.997	0.000
G80 Infantile cerebral palsy	0.003	0.997	0.000
G80.8 Other infantile cerebral palsy	0.003	0.997	0.000
N03.8 Other	0.003	0.997	0.000
N03.7 Diffuse crescentic glomerulonephritis	0.003	0.997	0.000
N03.6 Dense deposit disease	0.003	0.997	0.000
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.003	0.997	0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.003	0.997	0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.003	0.997	0.000
N03.2 Diffuse membranous glomerulonephritis	0.003	0.997	0.000
N03.1 Focal and segmental glomerular lesions	0.003	0.997	0.000
N03.0 Minor glomerular abnormality	0.003	0.997	0.000
J91 Pleural effusion in conditions classified elsewhere	0.000	0.997	0.003
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.998	0.002
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified	0.002	0.998	0.000
J39.2 Other diseases of pharynx	0.000	0.998	0.002
Z85.4 Personal history of malignant neoplasm of genital organs	0.000	0.998	0.002
Z92.6 Personal history of chemotherapy for neoplastic disease	0.000	0.998	0.002
Z11.2 Special screening examination for other bacterial diseases	0.000	0.998	0.002
H36 Retinal disorders in diseases classified elsewhere	0.002	0.998	0.000
B95.7 Other staphylococcus as the cause of diseases classified to other chapters	0.000	0.998	0.002
H16.0 Corneal ulcer	0.000	0.998	0.002
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
I84.4 External haemorrhoids with other complications	0.002	0.998	0.000
G80.9 Infantile cerebral palsy, unspecified	0.002	0.998	0.000
G80.4 Ataxic cerebral palsy	0.002	0.998	0.000
G80.3 Dyskinetic cerebral palsy	0.002	0.998	0.000
G80.2 Infantile hemiplegia	0.002	0.998	0.000
M94.88 Other specified disorders of cartilage (Other)	0.002	0.998	0.000
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.000	0.998	0.002
C43.5 Malignant melanoma of trunk	0.002	0.998	0.000
D61.9 Aplastic anaemia, unspecified	0.002	0.998	0.000
E87.2 Acidosis	0.000	0.998	0.002
Z00.6 Examination for normal comparison and control in clinical research programme	0.002	0.998	0.000
G44.8 Other specified headache syndromes	0.002	0.998	0.000
G44.0 Cluster headache syndrome	0.002	0.998	0.000
Z71.4 Alcohol abuse counselling and surveillance	0.002	0.998	0.000
I51.9 Heart disease, unspecified	0.000	0.998	0.002
Q23.1 Congenital insufficiency of aortic valve	0.000	0.998	0.002
Z71.7 Human immunodeficiency virus [HIV] counselling	0.002	0.998	0.000
Z71.5 Drug abuse counselling and surveillance	0.002	0.998	0.000
Z71.0 Person consulting on behalf of another person	0.002	0.998	0.000
M25.94 Joint disorder, unspecified (Hand)	0.002	0.998	0.000
H36.8 Other retinal disorders in diseases classified elsewhere	0.002	0.998	0.000
S64 Injury of nerves at wrist and hand level	0.000	0.998	0.002
S64.2 Injury of radial nerve at wrist and hand level	0.000	0.998	0.002
Y43 Primarily systemic agents	0.000	0.998	0.002
N13.4 Hydroureter	0.000	0.998	0.002
N36.2 Urethral caruncle	0.000	0.998	0.002
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.000	0.998	0.002
M25.9 Joint disorder, unspecified	0.002	0.998	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.002	0.998	0.000
Z71.1 Person with feared complaint in whom no diagnosis is made	0.002	0.998	0.000
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.000	0.998	0.002
H46-H48 Disorders of optic nerve and visual pathways	0.002	0.998	0.000
D72 Other disorders of white blood cells	0.002	0.998	0.000
M96.0 Pseudarthrosis after fusion or arthrodesis	0.002	0.998	0.000
M82.11 Osteoporosis in endocrine disorders (Shoulder region)	0.000	0.998	0.002
H47.3 Other disorders of optic disk	0.002	0.998	0.000
S64.1 Injury of median nerve at wrist and hand level	0.000	0.998	0.002
I05.9 Mitral valve disease, unspecified	0.002	0.998	0.000
G44 Other headache syndromes	0.002	0.998	0.000
M23.51 Chronic instability of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.002	0.998	0.000
I67.9 Cerebrovascular disease, unspecified	0.000	0.998	0.002
S64.9 Injury of unspecified nerve at wrist and hand level	0.000	0.998	0.002
S64.8 Injury of other nerves at wrist and hand level	0.000	0.998	0.002
S64.7 Injury of multiple nerves at wrist and hand level	0.000	0.998	0.002
Z71.6 Tobacco abuse counselling	0.002	0.998	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.000	0.998	0.002
I49.0 Ventricular fibrillation and flutter	0.000	0.998	0.002
T83.1 Mechanical complication of other urinary devices and implants	0.002	0.998	0.000
M95 Other acquired deformities of musculoskeletal system and connective tissue	0.000	0.998	0.002
M25.91 Joint disorder, unspecified (Shoulder region)	0.002	0.998	0.000
G59.0 Diabetic mononeuropathy	0.002	0.998	0.000
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.000	0.998	0.002
Y43.9 Primarily systemic agent, unspecified	0.000	0.998	0.002
Y43.8 Other primarily systemic agents, not elsewhere classified	0.000	0.998	0.002
Y43.6 Enzymes, not elsewhere classified	0.000	0.998	0.002
Y43.5 Acidifying and alkalising agents	0.000	0.998	0.002
Y43.2 Antineoplastic natural products	0.000	0.998	0.002
Y43.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
H47 Other disorders of optic [2nd] nerve and visual pathways	0.002	0.998	0.000
I50 Heart failure	0.000	0.998	0.002
N13.3 Other and unspecified hydronephrosis	0.000	0.998	0.002
M25.99 Joint disorder, unspecified (Site unspecified)	0.001	0.998	0.000
M25.98 Joint disorder, unspecified (Other)	0.001	0.998	0.000
M25.93 Joint disorder, unspecified (Forearm)	0.001	0.998	0.000
M25.92 Joint disorder, unspecified (Upper arm)	0.001	0.998	0.000
M25.90 Joint disorder, unspecified (Multiple sites)	0.001	0.998	0.000
C17.0 Duodenum	0.002	0.998	0.000
G44.4 Drug-induced headache, not elsewhere classified	0.002	0.998	0.000
G44.3 Chronic posttraumatic headache	0.002	0.998	0.000
U80.0 Penicillin resistant agent	0.002	0.998	0.000
M94.87 Other specified disorders of cartilage (Ankle and foot)	0.002	0.998	0.000
I51.7 Cardiomegaly	0.000	0.998	0.002
N13.9 Obstructive and reflux uropathy, unspecified	0.000	0.998	0.002
N13.6 Pyonephrosis	0.000	0.998	0.002
Z85 Personal history of malignant neoplasm	0.000	0.998	0.002
A09.0 Other and unspecified gastroenteritis and colitis of infectious origin	0.000	0.998	0.002
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.000	0.998	0.002
R01.1 Cardiac murmur, unspecified	0.002	0.998	0.000
H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere	0.001	0.998	0.000
D72.9 Disorder of white blood cells, unspecified	0.001	0.998	0.000
D72.0 Genetic anomalies of leukocytes	0.001	0.998	0.000
M94.8 Other specified disorders of cartilage	0.002	0.998	0.000
L05.9 Pilonidal cyst without abscess	0.000	0.998	0.002
Z85.5 Personal history of malignant neoplasm of urinary tract	0.000	0.998	0.002
M23.59 Chronic instability of knee (Unspecified ligament or Unspecified meniscus)	0.001	0.998	0.000
E61.1 Iron deficiency	0.000	0.998	0.001
G44.1 Vascular headache, not elsewhere classified	0.001	0.998	0.000
T14.6 Injury of tendons and muscles of unspecified body region	0.001	0.998	0.000
T14.0 Superficial injury of unspecified body region	0.002	0.998	0.000
X68.9 Unspecified place	0.001	0.998	0.000
N13 Obstructive and reflux uropathy	0.000	0.998	0.002
M07.3 Other psoriatic arthropathies	0.000	0.998	0.001
D72.1 Eosinophilia	0.001	0.998	0.000
M94.89 Other specified disorders of cartilage (Site unspecified)	0.001	0.998	0.000
E16.1 Other hypoglycaemia	0.001	0.998	0.000
G44.2 Tension-type headache	0.001	0.998	0.000
H47.2 Optic atrophy	0.001	0.998	0.000
L91.8 Other hypertrophic disorders of skin	0.000	0.999	0.001
M95.9 Acquired deformity of musculoskeletal system, unspecified	0.000	0.999	0.001
M95.8 Other specified acquired deformities of musculoskeletal system	0.000	0.999	0.001
M95.5 Acquired deformity of pelvis	0.000	0.999	0.001
M95.4 Acquired deformity of chest and rib	0.000	0.999	0.001
M95.3 Acquired deformity of neck	0.000	0.999	0.001
M95.1 Cauliflower ear	0.000	0.999	0.001
T14 Injury of unspecified body region	0.001	0.999	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.001	0.999	0.000
M25.95 Joint disorder, unspecified (Pelvic region and thigh)	0.001	0.999	0.000
H47.7 Disorder of visual pathways, unspecified	0.001	0.999	0.000
H47.6 Disorders of visual cortex	0.001	0.999	0.000
H47.5 Disorders of other visual pathways	0.001	0.999	0.000
H47.4 Disorders of optic chiasm	0.001	0.999	0.000
U80 Agent resistant to penicillin and related antibiotics	0.001	0.999	0.000
S64.3 Injury of digital nerve of thumb	0.000	0.999	0.001
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified	0.001	0.999	0.000
R39.1 Other difficulties with micturition	0.001	0.999	0.000
T14.1 Open wound of unspecified body region	0.001	0.999	0.000
Z71.2 Person consulting for explanation of investigation findings	0.001	0.999	0.000
Z85.0 Personal history of malignant neoplasm of digestive organs	0.000	0.999	0.001
Z85.9 Personal history of malignant neoplasm, unspecified	0.000	0.999	0.001
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.001	0.999	0.000
G95.1 Vascular myelopathies	0.000	0.999	0.001
H48.8 Other disorders of optic nerve and visual pathways in diseases classified elsewhere	0.001	0.999	0.000
H48.1 Retrobulbar neuritis in diseases classified elsewhere	0.001	0.999	0.000
H48.0 Optic atrophy in diseases classified elsewhere	0.001	0.999	0.000
T83.0 Mechanical complication of urinary (indwelling) catheter	0.001	0.999	0.000
M94.84 Other specified disorders of cartilage (Hand)	0.001	0.999	0.000
M94.83 Other specified disorders of cartilage (Forearm)	0.001	0.999	0.000
M94.82 Other specified disorders of cartilage (Upper arm)	0.001	0.999	0.000
M94.81 Other specified disorders of cartilage (Shoulder region)	0.001	0.999	0.000
M94.80 Other specified disorders of cartilage (Multiple sites)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations